Short-term outcomes in pregnant patients with COVID-19 who received nirmatrelvir–ritonavir treatment

By | November 15, 2022
Researchers investigated the short-term outcomes of treating pregnant patients exhibiting mild to moderate symptoms of COVID-19 with Paxlovid, which is a combination of the antivirals nirmatrelvir and ritonavir.